Dimensional Fund Advisors
NDRA icon

Dimensional Fund Advisors’s ENDRA Life Sciences NDRA Stock Holding History

Dimensional Fund Advisors’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-9
Closed -$35.3K – 3502
2023
Q1 		$35.3K Buy
+9
New +$61.1K ﹤0.01% 3412

Other funds holding NDRA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WAM
Worth Asset Management Dallas, Texas $313M AUM 37.93% 1-Year Est. Return

Dimensional Fund Advisors's NDRA Position: Q2 2023 in Review

Dimensional Fund Advisors sold out of ENDRA Life Sciences (NDRA) in Q2 2023, closing a stake of 9 shares — an estimated $35.3K sold.

Dimensional Fund Advisors first reported a position in NDRA in Q1 2023 and held it in 1 quarter. The position peaked at $35.3K in Q1 2023. 8 funds tracked by Wall St. Rank hold NDRA as of Q2 2023.

  • Dimensional Fund Advisors reported no remaining ENDRA Life Sciences position as of Q2 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 9 ENDRA Life Sciences shares in Q2 2023, an estimated $35.3K.
  • Dimensional Fund Advisors first reported a position in ENDRA Life Sciences in Q1 2023 and held it in 1 quarter.
  • Dimensional Fund Advisors's ENDRA Life Sciences position peaked at $35.3K in Q1 2023.
  • 8 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q2 2023.

Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.